TY - CHAP M1 - Book, Section TI - Congestive Heart Failure A1 - Yandrapalli, Srikanth A1 - Tariq, Sohaib A1 - Lanier, Gregg M. A2 - Go, Ronaldo Collo PY - 2019 T2 - Critical Care Examination and Board Review AB - Heart failure (HF) is the inability of the heart to pump an adequate supply of blood to meet the demands of the body. It is an epidemic and is associated with significant morbidity, mortality, and healthcare expenditure. Heart failure has an estimated prevalence of 5.8 million in the United States, and affects over 23 million people worldwide.1 The cost of HF in the United States was around $30 billion in 2012, a number that is projected to increase to around $70 billion by the year 2030.2 Acute decompensated HF (ADHF) is the clinical syndrome of new onset or worsening HF symptoms and signs requiring urgent treatment.3 In the United States, ADHF exacerbations result in about 1 million hospitalizations yearly and contribute largely to the overall HF healthcare expenditure.2 Hospitalization for ADHF serves as a poor prognostic indicator with an approximate 30% and 50% readmission rate at 1 month and 6 months, respectively, and a 1-year all-cause mortality as high as 30%.4,5 SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/28 UR - accessanesthesiology.mhmedical.com/content.aspx?aid=1160186152 ER -